✦ LIBER ✦

Mosaic Down syndrome-associated acute myeloid leukemia does not require high-dose cytarabine treatment for induction and consolidation therapy

✍ Scribed by Kazuko Kudo; Asahito Hama; Seiji Kojima; Ruriko Ishii; Akira Morimoto; Fumio Bessho; Shosuke Sunami; Naoyuki Kobayashi; Akitoshi Kinoshita; Yuri Okimoto; Akio Tawa; Ichiro Tsukimoto

Book ID: 107619001
Publisher: Carden Jennings Publishing
Year: 2010
Tongue: English
Weight: 206 KB
Volume: 91
Category: Article
ISSN: 0925-5710
DOI: 10.1007/s12185-010-0549-1

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Does high-dose cytarabine cause cumulati

Does high-dose cytarabine cause cumulative toxicity in patients undergoing consolidation therapy for acute myeloid leukemia?

✍ Wiernik, Andres; Sperr, Wolfgang R.; Weisdorf, Daniel; Valent, Peter; Ustun, Cel 📂 Article 📅 2013 🏛 John Wiley and Sons 🌐 English ⚖ 475 KB

A comparison of low-dose cytarabine and

A comparison of low-dose cytarabine and hydroxyurea with or without all-trans retinoic acid for acute myeloid leukemia and high-risk myelodysplastic syndrome in patients not considered fit for intensive treatment

✍ Alan K. Burnett; Donald Milligan; Archie G. Prentice; Anthony H. Goldstone; Mary 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 153 KB 👁 2 views